{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:12:19Z","timestamp":1792793539418,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jaut.2020.102444","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T07:36:30Z","timestamp":1586504190000},"page":"102444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["CXCL4 triggers monocytes and macrophages to produce PDGF-BB, culminating in fibroblast activation: Implications for systemic sclerosis"],"prefix":"10.1016","volume":"111","author":[{"given":"Maarten","family":"van der Kroef","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Carvalheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Rossato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floor","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Cossu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Chouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina G.K.","family":"Wichers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis P.J.","family":"Bekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Beretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Vazirpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Trombetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.D.J.","family":"Radstake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Angiolilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.jaut.2020.102444_bib1","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"Gabrielli","year":"2009","journal-title":"Scleroderma. N Engl J Med"},{"issue":"2","key":"10.1016\/j.jaut.2020.102444_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/BOR.0b013e32834ff2e8","article-title":"Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers","volume":"24","author":"Barnes","year":"2012","journal-title":"Curr. Opin. Rheumatol."},{"issue":"5","key":"10.1016\/j.jaut.2020.102444_bib3","first-page":"581","article-title":"Subcommittee for scleroderma criteria of the American rheumatism association diagnostic and therapeutic criteria committee","volume":"23","author":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","year":"1980","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.jaut.2020.102444_bib4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.jaut.2020.102444_bib5","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-018-1569-0","article-title":"Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression","volume":"20","author":"Bosello","year":"2018","journal-title":"Arthritis Res. Ther."},{"issue":"8","key":"10.1016\/j.jaut.2020.102444_bib6","first-page":"1202","article-title":"Macrophage infiltration in the skin of patients with systemic sclerosis","volume":"19","author":"Ishikawa","year":"1992","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.jaut.2020.102444_bib7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000163933","article-title":"Mononuclear cellular infiltrates in clinically involved skin from patients with systemic sclerosis of recent onset predominantly consist of monocytes\/macrophages","volume":"63","author":"Kraling","year":"1995","journal-title":"Pathobiology"},{"issue":"2","key":"10.1016\/j.jaut.2020.102444_bib8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/jcp.2004.019224","article-title":"Alterations of mononuclear inflammatory cells, CD4\/CD8+ T cells, interleukin 1beta, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis","volume":"58","author":"Hussein","year":"2005","journal-title":"J. Clin. Pathol."},{"issue":"4","key":"10.1016\/j.jaut.2020.102444_bib9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/annrheumdis-2018-214295","article-title":"Histone modifications underlie monocyte dysregulation in patients with systemic sclerosis, underlining the treatment potential of epigenetic targeting","volume":"78","author":"van der","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"5\u20136","key":"10.1016\/j.jaut.2020.102444_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000163802","article-title":"In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease","volume":"61","author":"Koch","year":"1993","journal-title":"Pathobiology"},{"issue":"7","key":"10.1016\/j.jaut.2020.102444_bib11","first-page":"1524","article-title":"Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis","volume":"30","author":"Furuse","year":"2003","journal-title":"J. Rheumatol."},{"issue":"6","key":"10.1016\/j.jaut.2020.102444_bib12","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/art.40455","article-title":"Skin gene expression is prognostic for the trajectory of skin disease in patients with diffuse cutaneous systemic sclerosis","volume":"70","author":"Stifano","year":"2018","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.jaut.2020.102444_bib13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"van Bon","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jaut.2020.102444_bib14","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1182\/blood.V95.4.1158.004k31_1158_1166","article-title":"The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages","volume":"95","author":"Scheuerer","year":"2000","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jaut.2020.102444_bib15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/eji.201948129","article-title":"Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and Sjogrens syndrome","volume":"50","author":"van der Kroef","year":"2020","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.jaut.2020.102444_bib16","doi-asserted-by":"crossref","first-page":"R128","DOI":"10.1186\/ar3066","article-title":"Characterization of monocyte\/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis","volume":"12","author":"Higashi-Kuwata","year":"2010","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.jaut.2020.102444_bib17","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood-2004-06-2475","article-title":"Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium","volume":"105","author":"von Hundelshausen","year":"2005","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jaut.2020.102444_bib18","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.4049\/jimmunol.0901368","article-title":"CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages","volume":"184","author":"Gleissner","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2020.102444_bib19","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.molimm.2019.09.004","article-title":"CXCL4 is a driver of cytokine mRNA stability in monocyte-derived dendritic cells","volume":"114","author":"Silva-Cardoso","year":"2019","journal-title":"Mol. Immunol."},{"issue":"4","key":"10.1016\/j.jaut.2020.102444_bib20","first-page":"463","article-title":"Proliferation and mitogenic response to PDGF-BB of fibroblasts isolated from chronic venous leg ulcers is ulcer-age dependent","volume":"112","author":"Agren","year":"1999","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2020.102444_bib21","series-title":"Role of PDGF in Fibrotic Diseases and Systemic Sclerosis","author":"Trojanowska","year":"2008"},{"issue":"9","key":"10.1016\/j.jaut.2020.102444_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162758","article-title":"PDGF-BB promotes type I IFN-dependent vascular alterations and monocyte recruitment in a model of dermal fibrosis","volume":"11","author":"Cho","year":"2016","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.jaut.2020.102444_bib23","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/ar2981","article-title":"Platelet-derived growth factor and transforming growth factor beta synergistically potentiate inflammatory mediator synthesis by fibroblast-like synoviocytes","volume":"12","author":"Rosengren","year":"2010","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.jaut.2020.102444_bib24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0268-960X(93)90024-X","article-title":"Platelet alpha-granules","volume":"7","author":"Harrison","year":"1993","journal-title":"Blood Rev."},{"key":"10.1016\/j.jaut.2020.102444_bib25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fimmu.2015.00070","article-title":"Are platelets cells? And if yes, are they immune cells?","volume":"6","author":"Garraud","year":"2015","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.jaut.2020.102444_bib26","doi-asserted-by":"crossref","first-page":"R128","DOI":"10.1186\/ar3066","article-title":"Characterization of monocyte\/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis","volume":"12","author":"Higashi-Kuwata","year":"2010","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.jaut.2020.102444_bib27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2217\/imt.13.173","article-title":"Potential use of TNF-alpha inhibitors in systemic sclerosis","volume":"6","author":"Murdaca","year":"2014","journal-title":"Immunotherapy"},{"issue":"2","key":"10.1016\/j.jaut.2020.102444_bib28","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/1097-4644(20010501)81:2<304::AID-JCB1045>3.0.CO;2-U","article-title":"The cell survival signal Akt is differentially activated by PDGF-BB, EGF, and FGF-2 in osteoblastic cells","volume":"81","author":"Chaudhary","year":"2001","journal-title":"J. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.jaut.2020.102444_bib29","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/1523-1747.ep12520933","article-title":"Variability in collagen and fibronectin synthesis by scleroderma fibroblasts in primary culture","volume":"76","author":"Fleischmajer","year":"1981","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2020.102444_bib30","first-page":"156","article-title":"Current management strategies for systemic sclerosis","author":"Nihtyanova","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2020.102444_bib31","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev-pathol-011110-130312","article-title":"The pathogenesis of systemic sclerosis","volume":"6","author":"Katsumoto","year":"2011","journal-title":"Annu. Rev. Pathol."},{"issue":"1","key":"10.1016\/j.jaut.2020.102444_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-27710-9","article-title":"CXCL4\/Platelet Factor 4 is an agonist of CCR1 and drives human monocyte migration","volume":"8","author":"Fox","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2020.102444_bib33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.imlet.2017.11.003","article-title":"Dendritic cells in systemic sclerosis: advances from human and mice studies","volume":"195","author":"Affandi","year":"2018","journal-title":"Immunol. Lett."},{"issue":"1","key":"10.1016\/j.jaut.2020.102444_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09683-z","article-title":"CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-alpha production in systemic sclerosis","volume":"10","author":"Lande","year":"2019","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.jaut.2020.102444_bib35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/1523-1747.ep12276895","article-title":"Immunohistologic demonstration of platelet-derived growth factor (PDGF) and sis-oncogene expression in scleroderma","volume":"92","author":"Gay","year":"1989","journal-title":"J. Invest. Dermatol."},{"issue":"10","key":"10.1016\/j.jaut.2020.102444_bib36","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/art.1780331011","article-title":"Increased expression of platelet-derived growth factor type B receptors in the skin of patients with systemic sclerosis","volume":"33","author":"Klareskog","year":"1990","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2020.102444_bib37","first-page":"S46","article-title":"Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis","volume":"29","author":"Riccieri","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.jaut.2020.102444_bib38","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0002-9343(97)00023-5","article-title":"Test performance in systemic sclerosis: anti-centromere and anti-Scl-70 antibodies","volume":"103","author":"Spencer-Green","year":"1997","journal-title":"Am. J. Med."},{"issue":"5\u20136","key":"10.1016\/j.jaut.2020.102444_bib39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000163802","article-title":"In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease","volume":"61","author":"Koch","year":"1993","journal-title":"Pathobiology"},{"issue":"4","key":"10.1016\/j.jaut.2020.102444_bib40","first-page":"663","article-title":"Elevated serum tumor necrosis factor-alpha levels in patients with systemic sclerosis: association with pulmonary fibrosis","volume":"24","author":"Hasegawa","year":"1997","journal-title":"J. Rheumatol."},{"issue":"10","key":"10.1016\/j.jaut.2020.102444_bib41","first-page":"1946","article-title":"Autocrine activation by interleukin 1alpha induces the fibrogenic phenotype of systemic sclerosis fibroblasts","volume":"31","author":"Kawaguchi","year":"2004","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.jaut.2020.102444_bib42","first-page":"5","article-title":"Expression of NLRP3 inflammasome, cytokines and vascular mediators in the skin of systemic sclerosis patients","volume":"17","author":"Martinez-Godinez","year":"2015","journal-title":"Isr. Med. Assoc. J."},{"issue":"4","key":"10.1016\/j.jaut.2020.102444_bib43","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/1523-1747.ep12483971","article-title":"Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6","volume":"97","author":"Duncan","year":"1991","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2020.102444_bib44","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.2741\/2955","article-title":"The roles of chemokines in leukocyte recruitment and fibrosis in systemic sclerosis","volume":"13","author":"Hasegawa","year":"2008","journal-title":"Front. Biosci."},{"issue":"4","key":"10.1016\/j.jaut.2020.102444_bib45","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cytogfr.2004.03.006","article-title":"Regulation of PDGF and its receptors in fibrotic diseases","volume":"15","author":"Bonner","year":"2004","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.jaut.2020.102444_bib46","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00000441-199307000-00011","article-title":"Regulation of fibroplasia in cutaneous wound repair","volume":"306","author":"Clark","year":"1993","journal-title":"Am. J. Med. Sci."},{"issue":"11","key":"10.1016\/j.jaut.2020.102444_bib47","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1002\/art.22186","article-title":"Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis","volume":"54","author":"Kissin","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.jaut.2020.102444_bib48","doi-asserted-by":"crossref","first-page":"e1004005","DOI":"10.1371\/journal.pcbi.1004005","article-title":"Systems level analysis of systemic sclerosis shows a network of immune and profibrotic pathways connected with genetic polymorphisms","volume":"11","author":"Mahoney","year":"2015","journal-title":"PLoS Comput. Biol."},{"issue":"6","key":"10.1016\/j.jaut.2020.102444_bib49","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/ard.2010.143974","article-title":"Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial","volume":"70","author":"Spiera","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.jaut.2020.102444_bib50","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/j.1365-2133.2012.11186.x","article-title":"Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial","volume":"167","author":"Prey","year":"2012","journal-title":"Br. J. Dermatol."},{"issue":"16","key":"10.1016\/j.jaut.2020.102444_bib51","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1158\/1078-0432.CCR-12-0625","article-title":"Crenolanib inhibits the drug-resistant PDGFRA D842V mutation associated with imatinib-resistant gastrointestinal stromal tumors","volume":"18","author":"Heinrich","year":"2012","journal-title":"Clin. Canc. Res."},{"issue":"8","key":"10.1016\/j.jaut.2020.102444_bib52","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.jid.2017.03.032","article-title":"Blockade of PDGF receptors by Crenolanib has therapeutic effect in patient fibroblasts and in preclinical models of systemic sclerosis","volume":"137","author":"Makino","year":"2017","journal-title":"J. Invest. Dermatol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841120300573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841120300573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:25:00Z","timestamp":1760257500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841120300573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":52,"alternative-id":["S0896841120300573"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2020.102444","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CXCL4 triggers monocytes and macrophages to produce PDGF-BB, culminating in fibroblast activation: Implications for systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2020.102444","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102444"}}